|
Toll Free: (877) 796-6397 -- USA and Canada only -- |
Fax: +1-832-582-8590 Orders: +1-832-582-8158 |
Tech Support: +1-832-582-8158 Ext:3 Please provide your Order Number in the email. |
Technical Data
| Formula | C89H126N24O18S |
|||
| Molecular Weight | 1852.17 | CAS No. | 1629654-95-0 | |
| Solubility (25°C)* | In vitro | Water | 100 mg/mL (53.99 mM) | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.) |
||||
Preparing Stock Solutions
Biological Activity
| Description | PD-1/PD-L1 Inhibitor 3（Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 3）is a Macrocyclic inhibitor of PD-1/PD-L1 interaction with IC50 of 5.6 nM | ||
|---|---|---|---|
| Targets |
|
||
| In vitro | PD-1/PD-L1 Inhibitor 3 is capable of inhibiting the interaction of PD-L1 with PD-1 and with CD80. It has highly efficacious binding to PD-L1 and promotes enhanced T cell functional activity[1]. |
Protocol (from reference)
Selleck's PD-1/PD-L1 Inhibitor 3 has been cited by 12 publications
| Development and In Vivo Evaluation of Small-Molecule Ligands for Positron Emission Tomography of Immune Checkpoint Modulation Targeting Programmed Cell Death 1 Ligand 1 [ J Med Chem, 2024, 67(5):4036-4062] | PubMed: 38442487 |
| On the Road towards Small-Molecule Programmed Cell Death 1 Ligand 1 Positron Emission Tomography Tracers: A Ligand-Based Drug Design Approach [ Pharmaceuticals (Basel), 2023, 16(7)1051] | PubMed: 37513962 |
| Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells [ Biochem Pharmacol, 2022, 197:114940] | PubMed: 35120895 |
| Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells [ Biochem Pharmacol, 2022, 197:114940] | PubMed: 35120895 |
| FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer [ ChemMedChem, 2022, e202200091] | PubMed: 35388635 |
| A mating mechanism to generate diversity for the Darwinian selection of DNA-encoded synthetic molecules [ Nat Chem, 2021, 10.1038/s41557-021-00829-5] | PubMed: 34873299 |
| MRTF-A-NF-κB/p65 axis-mediated PDL1 transcription and expression contributes to immune evasion of non-small-cell lung cancer via TGF-β [ Exp Mol Med, 2021, 53(9):1366-1378] | PubMed: 34548615 |
| The Stone Guest: How Does pH Affect Binding Properties of PD-1/PD-L1 Inhibitors [ ChemMedChem, 2021, 16(3):568-577] | PubMed: 33085193 |
| Blockade of Kv1.3 potassium channel inhibits CD8+ T cell-mediated neuroinflammation via PD-1/Blimp-1 signaling [ FASEB J, 2020, 10.1096/fj.202000861RR] | PubMed: 32981181 |
| eEF2K enhances expression of PD-L1 by promoting the translation of its mRNA [ Biochem J, 2020, BCJ20200697] | PubMed: 33094805 |
RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.
NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.